
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $298.2M | -- | -- | $0.39 | -- |
07/24/2025 | Q2 | $304.4M | -- | -- | $0.37 | -- |
04/23/2025 | Q1 | $290.2M | $306.6M | $0.64 | $0.55 | $0.09 |
02/05/2025 | Q4 | $348.8M | $438.7M | $1.15 | $0.49 | $0.66 |
10/23/2024 | Q3 | $273.6M | $273.8M | $0.22 | $0.19 | $0.03 |
07/24/2024 | Q2 | $227.9M | $264.6M | $0.17 | $0.10 | $0.07 |
04/24/2024 | Q1 | $219.8M | $217.5M | $0.22 | $0.14 | $0.08 |
02/07/2024 | Q4 | $197.9M | $214.9M | -$0.08 | -$0.11 | $0.03 |
11/02/2023 | Q3 | -- | -- | -$0.16 | $0.04 | -$0.20 |
07/26/2023 | Q2 | -- | -- | -$0.17 | -$0.01 | -$0.16 |
04/26/2023 | Q1 | -- | -- | $0.05 | $0.10 | -$0.05 |
02/08/2023 | Q4 | -- | -- | $0.28 | $0.33 | -$0.05 |
11/02/2022 | Q3 | -- | -- | $0.37 | $0.35 | $0.02 |
07/27/2022 | Q2 | -- | -- | $0.56 | $0.43 | $0.13 |
04/27/2022 | Q1 | -- | -- | $0.94 | $0.77 | $0.17 |
02/09/2022 | Q4 | -- | -- | $1.41 | $1.49 | -$0.08 |
10/27/2021 | Q3 | -- | -- | $1.76 | $1.35 | $0.41 |
07/21/2021 | Q2 | -- | -- | $1.17 | $0.83 | $0.34 |
04/28/2021 | Q1 | -- | -- | $1.00 | $0.87 | $0.13 |
02/10/2021 | Q4 | -- | -- | $1.97 | $1.34 | $0.63 |
10/26/2020 | Q3 | -- | -- | $0.54 | $0.03 | $0.51 |
07/29/2020 | Q2 | -- | -- | -$0.10 | -$0.13 | $0.03 |
04/22/2020 | Q1 | -- | -- | $0.44 | $0.34 | $0.10 |
02/05/2020 | Q4 | -- | -- | $0.38 | $0.26 | $0.12 |
10/30/2019 | Q3 | -- | -- | $0.73 | $0.57 | $0.16 |
07/30/2019 | Q2 | -- | -- | $0.56 | $0.42 | $0.14 |
04/30/2019 | Q1 | -- | -- | $0.27 | $0.24 | $0.03 |
02/06/2019 | Q4 | -- | -- | $0.77 | $0.67 | $0.10 |
10/22/2018 | Q3 | -- | -- | $0.62 | $0.64 | -$0.02 |
07/23/2018 | Q2 | -- | -- | $0.78 | $0.55 | $0.23 |
04/23/2018 | Q1 | -- | -- | $0.84 | $0.72 | $0.12 |
02/07/2018 | Q4 | -- | -- | $0.52 | $0.42 | $0.10 |
10/25/2017 | Q3 | -- | -- | $0.57 | $0.42 | $0.15 |
07/24/2017 | Q2 | -- | -- | $0.66 | $0.48 | $0.18 |
04/25/2017 | Q1 | -- | -- | $0.54 | $0.41 | $0.13 |
02/08/2017 | Q4 | -- | -- | $0.66 | $0.61 | $0.05 |
10/26/2016 | Q3 | -- | -- | $0.44 | $0.34 | $0.10 |
08/03/2016 | Q2 | -- | -- | $0.35 | $0.31 | $0.04 |
04/27/2016 | Q1 | -- | -- | $0.35 | $0.31 | $0.04 |
02/09/2016 | Q4 | -- | -- | $0.55 | $0.51 | $0.04 |
10/28/2015 | Q3 | -- | -- | $0.49 | $0.40 | $0.09 |
Moelis & reported $306.6M worth of top line sales in its most recent quarter.
Moelis & announced earnings per share of $0.64 which represents a beat of analyst forecast a $0.55 per share.
Moelis & reported $95M that represents $1.21 per share over the last quarter.
Moelis &'s earnings are forecast to grow from $1.78 per share to $1.12 per share next year representing an increase of 9.24%.
Moelis &'s next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.